| Revenue Information |
Note 11 – Revenue Information
Revenue by product lines was as follows:
| |
|
Three months ended |
|
|
Nine months ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Product Line |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
$ |
(18,798 |
) |
|
$ |
104,094 |
|
|
$ |
106,832 |
|
|
$ |
259,601 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
567,262 |
|
|
|
490,058 |
|
|
|
1,183,327 |
|
|
|
1,477,726 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
- |
|
|
|
27,500 |
|
|
|
55,000 |
|
|
|
27,500 |
|
| Other |
|
|
8,625 |
|
|
|
16,679 |
|
|
|
41,006 |
|
|
|
613,614 |
|
| Product Revenue Total |
|
|
557,089 |
|
|
|
638,331 |
|
|
|
1,386,165 |
|
|
|
2,378,441 |
|
| License Fees |
|
|
- |
|
|
|
37,500 |
|
|
|
- |
|
|
|
37,500 |
|
| Total Revenue |
|
$ |
557,089 |
|
|
$ |
675,831 |
|
|
$ |
1,386,165 |
|
|
$ |
2,415,941 |
|
The total revenue by geographic area
determined based on the location of the customers was as follows:
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Geographic Region |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| United States |
|
$ |
554,269 |
|
|
$ |
626,077 |
|
|
$ |
1,311,360 |
|
|
$ |
1,755,558 |
|
| People’s Republic of China |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
502,268 |
|
| Rest of World |
|
|
2,820 |
|
|
|
49,754 |
|
|
|
74,805 |
|
|
|
158,115 |
|
| Total Revenue |
|
$ |
557,089 |
|
|
$ |
675,831 |
|
|
$ |
1,386,165 |
|
|
$ |
2,415,941 |
|
The Company had long-lived assets
totaling $59,355 and $59,830 located in the People’s Republic of China and $1,201,592 and $1,305,950 located in the United
States as of September 30, 2018 and December 31, 2017, respectively.
|